Literature DB >> 19763758

Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration.

Yasuhiko Hirami1, Michiko Mandai, Masayo Takahashi, Satoshi Teramukai, Harue Tada, Nagahisa Yoshimura.   

Abstract

PURPOSE: To comprehend the clinical characteristics and factors related to visual prognosis in two major subtypes of neovascular age-related macular degeneration (AMD)-traditional, typical AMD and polypoidal choroidal vasculopathy (PCV).
METHODS: Medical records of 272 eyes of 216 patients diagnosed with neovascular AMD at Kyoto University Hospital between January 2000 and March 2003 were retrospectively reviewed for up to 3 years. Ophthalmoscopic, angiographic, and optical coherence tomography (OCT) findings were collected, and univariate and multivariate analyses were performed to determine the characteristic factors, the factors associated with initial visual acuity (VA), and visual prognosis in typical AMD and PCV.
RESULTS: We studied 154 eyes with typical AMD and 117 eyes with PCV. The presence of classic choroidal neovascularization (CNV) and posterior confluent drusen were characteristic of typical AMD, whereas PCV was characterized by a larger number of retinal pigment epithelial detachments and a small number of drusen. Poor initial VA (<0.1) was significantly associated with subfoveal classic CNV, hard exudates, late fibrosis staining of >or =1 disc area in AMD, and with blood and cystoid macular edema in PCV. Maintenance of good VA was associated with better initial VA in typical AMD and with smaller lesions in PCV.
CONCLUSION: Typical AMD and PCV revealed statistical differences both in their clinical characteristics and in the factors associated with visual prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19763758     DOI: 10.1007/s10384-009-0669-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  26 in total

Review 1.  Age-related macular degeneration.

Authors:  S L Fine; J W Berger; M G Maguire; A C Ho
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

2.  Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-09

3.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

4.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.

Authors:  L A Yannuzzi; A Ciardella; R F Spaide; M Rabb; K B Freund; D A Orlock
Journal:  Arch Ophthalmol       Date:  1997-04

5.  Clinical application of indocyanine green angiography to choroidal neovascularization.

Authors:  K Hayashi; Y Hasegawa; Y Tazawa; J J de Laey
Journal:  Jpn J Ophthalmol       Date:  1989       Impact factor: 2.447

6.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

Review 7.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

8.  Classification of choroidal neovascularization by digital indocyanine green videoangiography.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; P Hanutsaha; R F Spaide; S G Schwartz; J M Hirschfeld; D A Orlock
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

9.  Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study.

Authors:  A Okubo; M Sameshima; A Uemura; S Kanda; N Ohba
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

10.  Polypoidal choroidal vasculopathy in elderly Chinese patients.

Authors:  Feng Wen; Changzheng Chen; Dezheng Wu; Haitao Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-29       Impact factor: 3.117

View more
  12 in total

1.  Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Authors:  Ebenezer Daniel; James Shaffer; Gui-shuang Ying; Juan E Grunwald; Daniel F Martin; Glenn J Jaffe; Maureen G Maguire
Journal:  Ophthalmology       Date:  2015-12-08       Impact factor: 12.079

2.  Baseline data from a multicenter, 5-year, prospective cohort study of Japanese age-related macular degeneration: an AMD2000 report.

Authors:  Akitaka Tsujikawa; Yumiko Akagi-Kurashige; Mitsuko Yuzawa; Tatsuro Ishibashi; Hideo Nakanishi; Eiji Nakatani; Satoshi Teramukai; Masanori Fukushima; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2017-12-21       Impact factor: 2.447

3.  Potential selection bias in candidates for stereotactic radiotherapy for neovascular AMD.

Authors:  Christoph Ehlken; Daniel Böhringer; Hansjürgen T Agostini; Bastian Grundel; Milena Stech
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-22       Impact factor: 3.117

4.  A 5-year multicenter prospective cohort study on the long-term visual prognosis and predictive factors for visual outcome in Japanese patients with age-related macular degeneration: the AMD2000 study.

Authors:  Yumiko Akagi-Kurashige; Akitaka Tsujikawa; Mitsuko Yuzawa; Tatsuro Ishibashi; Hideo Nakanishi; Eiji Nakatani; Satoshi Teramukai; Masanori Fukushima; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2017-12-09       Impact factor: 2.447

5.  Association between photoreceptor integrity and visual outcome in diabetic macular edema.

Authors:  Hyun Jin Shin; Seung Hyen Lee; Hyewon Chung; Hyung Chan Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-27       Impact factor: 3.117

6.  Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.

Authors:  John S Wittenborn; Traci Clemons; Carl Regillo; Nadim Rayess; Danielle Liffmann Kruger; David Rein
Journal:  JAMA Ophthalmol       Date:  2017-05-01       Impact factor: 7.389

7.  PI3K-mediated glioprotective effect of epidermal growth factor under oxidative stress conditions.

Authors:  Zhi-Xiang Hu; Chun-Li Chen; Jia-Song Yang; Zhong-Lou Zhou; Zong-Ming Song; Zhao-Yang Wang
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

8.  Response to anti-VEGF therapy in patients with subretinal fluid and pigment epithelial detachment on spectral-domain optical coherence tomography.

Authors:  Lebriz Ersoy; Tina Ristau; Bernd Kirchhof; Sandra Liakopoulos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-26       Impact factor: 3.117

9.  Attenuation of choroidal neovascularization by histone deacetylase inhibitor.

Authors:  Nymph Chan; Shikun He; Christine K Spee; Keijiro Ishikawa; David R Hinton
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

Review 10.  Association of Genes in the High-Density Lipoprotein Metabolic Pathway with Polypoidal Choroidal Vasculopathy in Asian Population: A Systematic Review and Meta-Analysis.

Authors:  Ming-Zhen Yuan; Ruo-An Han; Chen-Xi Zhang; You-Xin Chen
Journal:  J Ophthalmol       Date:  2018-06-06       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.